Henry Fuchs
Technik-/Wissenschafts-/F&E-Leiter bei BIOMARIN PHARMACEUTICAL INC.
Vermögen: 16 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Alexander Hardy | M | 56 | 1 Jahre | |
| Randy Meier | M | 65 | 18 Jahre | |
| David Pyott | M | 70 | 8 Jahre | |
| Stuart Bunting | M | - | 16 Jahre | |
| Barbara Bodem | F | 56 | 1 Jahre | |
| Elizabeth Anderson | F | 66 | 5 Jahre | |
| Willard Dere | M | 70 | 8 Jahre | |
| Philip Lo Scalzo | M | - | 17 Jahre | |
| Athena Countouriotis | M | 52 | 1 Jahre | |
| Robert Hombach | M | 58 | 7 Jahre | |
| Brian Mueller | M | 50 | 22 Jahre | |
| May Kin Ho | M | 71 | 3 Jahre | |
| Elaine Heron | M | 76 | 22 Jahre | |
| George Davis | M | 53 | 20 Jahre | |
| Mark Enyedy | M | 60 | 1 Jahre | |
| Brinda Balakrishnan | M | 44 | 8 Jahre | |
| Erin Burkhart | F | 45 | 2 Jahre | |
| Ganesh Vedantham | M | - | 3 Jahre | |
| Marni Kottle | F | - | - | |
| C. Guyer | M | 62 | 4 Jahre | |
| Amy Wireman | F | - | 11 Jahre | |
| Kevin Eggan | M | - | 4 Jahre | |
| Brad Glasscock | M | - | 12 Jahre | |
| Dave Jacoby | M | - | 8 Jahre | |
| Kevin Conroy | M | 58 | 5 Jahre | |
| D. Coward | M | 59 | 5 Jahre | |
| Traci McCarty | F | - | - | |
| Eduardo Von Pervieux | M | - | 16 Jahre | |
| Jeffrey Elliott | M | 46 | 5 Jahre | |
| Humaira Serajuddin | F | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kim Popovits | F | 65 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 32 Jahre |
| Charles Grubsztajn | M | - | 7 Jahre | |
| N. Coles | M | 63 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 Jahre |
| Jean-Jacques Bienaimé | M | 70 | 19 Jahre | |
| Charles Baum | M | 65 | 12 Jahre | |
| Dean Schorno | M | 61 | 13 Jahre | |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 30 Jahre |
| Michael Grey | M | 71 | 16 Jahre | |
| Felix Baker | M | 55 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 9 Jahre |
| Kimberly Manhard | F | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 10 Jahre |
| Barry Quart | M | 67 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 7 Jahre |
| Craig Johnson | M | 62 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 Jahre |
| Mark Gergen | M | 61 | 3 Jahre | |
| Rodney Lappe | M | 69 | 7 Jahre | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 Jahre |
| Perry Johnston | M | - | - | |
| Pierre LaPalme | M | 83 | 12 Jahre | |
| Martin Godbout | M | - | 12 Jahre | |
| V. Lawlis | M | 72 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 33 Jahre |
| Hollings Renton | M | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 15 Jahre |
| Mark Wood | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 Jahre |
| Dan Spiegelman | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 16 Jahre |
| Vickie Reed | F | 62 | 9 Jahre | |
| Adora Ndu | M | 43 | 5 Jahre | |
| Geoffrey Parker | M | 59 | 3 Jahre | |
| Wendy Dixon | M | 68 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 1 Jahre |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 Jahre |
| Christian Waage | M | 57 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 4 Jahre |
| Andrew Hindman | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Neil Reisman | M | 62 | 1 Jahre | |
| Frederic Pla | M | 65 | 6 Jahre | |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 Jahre |
| James J. Vaughn | M | 61 | - | |
| David Meek | M | 59 | 2 Jahre | |
| Dennis Joseph Slamon | M | 75 | 10 Jahre | |
| Sandra Shpilberg | F | 48 | 9 Jahre | |
| Peter Radovich | M | 46 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
| Temre Johnson | M | - | 5 Jahre | |
| Aaron Davis | M | 45 | 6 Jahre | |
| Steve Maricich | M | - | 3 Jahre | |
| Maya Martinez-Davis | F | 54 | 6 Jahre | |
| Reena Desai | F | - | - | |
| Jason W. Radford | M | 42 | 4 Jahre | |
| Mark Alles | M | 64 | 2 Jahre | |
| Jeff Ajer | M | 61 | 19 Jahre | |
| Jack S. Remington | M | 93 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 Jahre |
| William Young | M | 79 | 5 Jahre | |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 Jahre |
| Louis P. Lacasse | M | 67 | 11 Jahre | |
| Marilyn E. Wortzman | F | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 Jahre |
| Stephen Aselage | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 Jahre |
| Bruce Carter | M | 80 | 8 Jahre | |
| Amy P. Sing | M | 65 | - | |
| Alan J. Lewis | M | 78 | 15 Jahre | |
| Colin R. Mallet | M | 80 | 11 Jahre | |
| Randall Livingston | M | 70 | 12 Jahre | |
| William Ringo | M | 78 | 2 Jahre | |
| Marcy Graham | F | 57 | - | |
| Leonard Post | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 Jahre |
| Faheem Hasnain | M | 65 | 5 Jahre | |
| Kathy Hibbs | F | 60 | 5 Jahre | |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 Jahre |
| Julian Baker | M | 57 | 18 Jahre | |
| John W. Poyhonen | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 Jahre |
| Fred Cohen | M | 67 | 17 Jahre | |
| Julie Cherrington | M | 66 | 5 Jahre | |
| Barry Flannelly | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 Jahre |
| Joshua Grass | M | - | 14 Jahre | |
| Shalini Sharp | F | 49 | 3 Jahre | |
| Aaron Ondrey | M | 48 | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Henry Fuchs
- Persönliches Netzwerk
